23 December 2021
Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Aptamer Group Plc on its £80.7 million AIM IPO. On Admission, the market capitalisation of Aptamer Group was approximately £80.7 million. The Placing raised gross proceeds of £10.8 million and attracted strong support from high-quality institutional investors.
24 November 2021
Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Technology Minerals Plc on its £27.3 million IPO on the Standard Segment of LSE’s Main Market.
20 July 2021
Poolbeg Pharma, a spin out of Open Orphan, has successfully raised £25 million (before expenses) and lists with a market capitalisation of £50 million. Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company. Their novel capital light clinical model enables them to develop multiple products faster and more cost effectively than the traditional biotech model.
3 November 2020
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Anemoi International ("AMOI") on its IPO on the Standard Segment of LSE’s main market.
6 October 2020
Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Mode Global Holdings Plc, a UK based founder led fintech group, on its £40.3 million IPO on the Standard Segment of LSE’s main market.
21 July 2020
We are delighted to announce that our specialist Capital Markets team have been shortlisted for one of the most hotly-contested trophies in the accountancy profession: Specialist Team of the Year 2020.
